
PolyCore Therapeutics Appoints Christopher M. Cashman to Board of Directors
PHILADELPHIA, Pa, February 22, 2021 – PolyCore Therapeutics LLC, a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative… Read More